APA

Lee J., Chen T. W., Hsu C., Yen Y., Yang J. C., Cheng A., Sasaki S., Chiu L. L., Sugihara M., Ishizuka T., Oguma T., Tajima N. & Lin C. (20201023). A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors. : Investigational new drugs.

Chicago

Lee Jih-Hsiang, Chen Tom Wei-Wu, Hsu Chih-Hung, Yen Yu-Hsin, Yang James Chih-Hsin, Cheng Ann-Lii, Sasaki Shun-Ichi, Chiu LiYin Lillian, Sugihara Masahiro, Ishizuka Tomoko, Oguma Toshihiro, Tajima Naoyuki and Lin Chia-Chi. 20201023. A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors. : Investigational new drugs.

Harvard

Lee J., Chen T. W., Hsu C., Yen Y., Yang J. C., Cheng A., Sasaki S., Chiu L. L., Sugihara M., Ishizuka T., Oguma T., Tajima N. and Lin C. (20201023). A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors. : Investigational new drugs.

MLA

Lee Jih-Hsiang, Chen Tom Wei-Wu, Hsu Chih-Hung, Yen Yu-Hsin, Yang James Chih-Hsin, Cheng Ann-Lii, Sasaki Shun-Ichi, Chiu LiYin Lillian, Sugihara Masahiro, Ishizuka Tomoko, Oguma Toshihiro, Tajima Naoyuki and Lin Chia-Chi. A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors. : Investigational new drugs. 20201023.